Skip to main content

Table 2 Response to GT Regimen in 52 patients by RECIST

From: Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?

  Number of patients % Mean cycles
CR 0 0
PR 0 0
SD 5 9.6% 4.8
PD 47 90.4% 3.2
Reason for PD
 New lesions 12 23.1%
 Lesions enlargement 25 48.1%
 Both 15 28.8%